JP2002506648A5 - - Google Patents

Download PDF

Info

Publication number
JP2002506648A5
JP2002506648A5 JP2000536863A JP2000536863A JP2002506648A5 JP 2002506648 A5 JP2002506648 A5 JP 2002506648A5 JP 2000536863 A JP2000536863 A JP 2000536863A JP 2000536863 A JP2000536863 A JP 2000536863A JP 2002506648 A5 JP2002506648 A5 JP 2002506648A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
subject
composition according
vaccination
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000536863A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002506648A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK1999/000136 external-priority patent/WO1999047680A1/en
Publication of JP2002506648A publication Critical patent/JP2002506648A/ja
Publication of JP2002506648A5 publication Critical patent/JP2002506648A5/ja
Pending legal-status Critical Current

Links

JP2000536863A 1998-03-16 1999-03-16 突然変異体組換えアレルゲン Pending JP2002506648A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK36498 1998-03-16
DK0364/98 1998-03-16
PCT/DK1999/000136 WO1999047680A1 (en) 1998-03-16 1999-03-16 Mutant recombinant allergens

Publications (2)

Publication Number Publication Date
JP2002506648A JP2002506648A (ja) 2002-03-05
JP2002506648A5 true JP2002506648A5 (enExample) 2006-05-11

Family

ID=8092687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000536863A Pending JP2002506648A (ja) 1998-03-16 1999-03-16 突然変異体組換えアレルゲン

Country Status (19)

Country Link
US (1) US20040091500A1 (enExample)
EP (1) EP1062341B1 (enExample)
JP (1) JP2002506648A (enExample)
KR (1) KR20010041918A (enExample)
CN (1) CN1332029C (enExample)
AT (1) ATE408690T1 (enExample)
AU (1) AU749749B2 (enExample)
CA (1) CA2323687C (enExample)
DE (1) DE69939584D1 (enExample)
DK (1) DK1062341T3 (enExample)
ES (1) ES2313776T3 (enExample)
HU (1) HUP0101464A3 (enExample)
IL (2) IL138339A0 (enExample)
NO (1) NO328354B1 (enExample)
NZ (1) NZ506665A (enExample)
PL (1) PL194804B1 (enExample)
PT (1) PT1062341E (enExample)
WO (1) WO1999047680A1 (enExample)
ZA (1) ZA200004819B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020192792A1 (en) * 2000-04-28 2002-12-19 Palle Schneider Laccase mutants
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
IT1318690B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti dell'allergene maggiore par j 2 di parietaria judaica.
EP1340085B1 (en) * 2000-10-17 2008-07-30 Besst-Test Aps Assay for directly detecting a biological cell in a body fluid sample
DE60136653D1 (de) * 2000-11-16 2009-01-02 Alk Abello As Mutante allergene
DK1219300T3 (da) * 2000-12-28 2007-03-05 Biomay Prod & Handel Behandling af allergi
ATE448793T1 (de) * 2001-03-02 2009-12-15 Univ Rockefeller Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
EP1436627A2 (en) * 2001-10-05 2004-07-14 Novozymes A/S Kit for predicting binding of a specific antibody to a potential immunogen and method of screening
WO2003072601A1 (de) * 2002-02-27 2003-09-04 Merck Patent Gmbh VERFAHREN ZUR HERSTELLUNG VON HYPOALLERGENEM BIRKENPOLLENHAUPTALLERGEN rBet v 1
EP1504089A2 (en) * 2002-05-16 2005-02-09 Alk Abell A/S Allergen mutants
WO2004039834A2 (en) * 2002-11-01 2004-05-13 Alk-Abelló A/S Recombinant protein variants
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
CA2516291C (en) 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
WO2005058474A1 (en) 2003-12-19 2005-06-30 Alk-Abelló A/S Cryogranulation and storage method for active pharmaceutical agents
AU2006299310A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
ITMI20052517A1 (it) * 2005-12-29 2007-06-30 Lofarma Spa Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa
CN101473028B (zh) * 2006-04-20 2012-11-07 新加坡国立大学 重组乳杆菌及其用途
EP2481418A1 (en) * 2007-02-15 2012-08-01 MannKind Corporation A method for enhancing T cell response
EP1974746B1 (en) 2007-03-28 2012-01-11 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
EP2028188A1 (en) * 2007-08-21 2009-02-25 Biomay AG Hypoallergenic molecules
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
EP2442828B1 (en) 2009-06-19 2016-08-03 Alk-Abelló S.A. Novel manner of administrating allergen in allergen specific immunotherapy
CN102584966A (zh) * 2011-11-14 2012-07-18 广州医学院第二附属医院 一种重组花生过敏原与突变体及其制备方法和应用
CN102690340A (zh) * 2012-03-30 2012-09-26 广州医学院第二附属医院 一种重组巴西坚果过敏原与突变体及其制备方法和应用
CN102603879A (zh) * 2012-03-30 2012-07-25 广州医学院第二附属医院 一种重组大豆过敏原与突变体及其制备方法和应用
CN102617715A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组真菌主要过敏原与突变体及其制备方法和应用
CN102617719A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组大米过敏原与突变体及其制备方法和应用
CN102675439A (zh) * 2012-03-31 2012-09-19 广州医学院第二附属医院 一种重组黑麦草花粉过敏原与突变体的制备方法和应用
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
EP4058059B1 (en) * 2019-11-13 2024-10-09 The Regents Of The University Of Michigan Nanoemulsion compositions for treating aeroallergen associated allergy and inflammation
CN111187606B (zh) * 2020-02-25 2022-06-14 江苏海洋大学 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
DE69940805D1 (de) * 1998-01-31 2009-06-10 Sinai School Medicine Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.

Similar Documents

Publication Publication Date Title
JP2002506648A5 (enExample)
JP2004523498A5 (enExample)
JP2004529078A5 (enExample)
JP2004532810A5 (enExample)
JP2004525194A5 (enExample)
JP2004515500A5 (enExample)
JP2002511411A5 (enExample)
JP2003520232A5 (enExample)
JP2000507362A5 (enExample)
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
JP2001131087A5 (enExample)
DK1399133T4 (da) Sammensætning med langvarig frigivelse omfattende mælkesyre-glykolsyre-copolymer samt fremgangsmåde til fremstilling heraf
JP2002523184A5 (enExample)
ATE485833T1 (de) Pharmazeutische zusammensetzungen, die die immunogenität von schwach immunogenen antigenen fördern
JP2004534810A5 (enExample)
JP2000141643A5 (enExample)
BG101401A (bg) Състави за орално приложение с удължено освобождаване на цисаприд
JP2001524364A5 (enExample)
WO2002053149A3 (de) Arzneimittel enthaltend ein polyamin als wirksubstanz
JP2002114686A5 (enExample)
SE0001916D0 (sv) Novel formulation
JP2000095900A5 (enExample)
JPH10237071A5 (enExample)
JP2000319390A5 (enExample)
JP2002531135A5 (enExample)